Knockdown of AKT3 (PKB γ) and PI3KCA suppresses cell viability and proliferation and induces the apoptosis of glioblastoma multiforme T98G cells

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Paul Samojedny, Monika ^a   Suchanek, Renata ^a   Borkowska, Paulina ^a   Pudełko, Adam ^a   Owczarek, Aleksander ^a   Kowalczyk, Małgorzata ^a   Machnik, Grzegorz ^a   Fila Daniłow, Anna ^a   Kowalski, Jan ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3 KINASE CATALYTIC ALPHA POLYPEPTIDE; PROTEIN BAX; PROTEIN BCL 2; PROTEIN KINASE B; PROTEIN KINASE B GAMMA; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; AKT3 PROTEIN, HUMAN; NUCLEAR PROTEIN; PI3KCA PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

APOPTOSIS; ARTICLE; CELL CYCLE G2 PHASE; CELL DEATH; CELL GROWTH; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; FLOW CYTOMETRY; GENE EXPRESSION; GENE SILENCING; GENETIC TRANSFECTION; GLIOBLASTOMA; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TUMOR CELL; UPREGULATION; WESTERN BLOTTING; CELL CYCLE; CELL LINE; CELL SURVIVAL; ENZYMOLOGY; GENETICS; MALE; METABOLISM; MIDDLE AGED;

APOPTOSIS; CELL CYCLE; CELL LINE; CELL SURVIVAL; GENE KNOCKDOWN TECHNIQUES; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; NUCLEAR PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; TRANSCRIPTION FACTORS;

EID: 84902265135     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/768181     Document Type: Article

References (49)

1. Weber G. L., Parat M.-O., Binder Z. A., Gallia G. L., Riggins G. J., Abrogation of PIK3CA or PIK3R1 reduces proliferation, migration, and invasion in glioblastoma multiforme cells. Oncotarget 2011 2 11 833 849 2-s2.0-84857204726
2. Dai C., Holland E. C., Astrocyte differentiation states and glioma formation. Cancer Journal 2003 9 2 72 81 2-s2.0-0141835824 10.1097/00130404- 200303000-00002
3. Burgering B. M. T., Coffer P. J., Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 1995 376 6541 599 602 2-s2.0-0029160069
4. Mure H., Matsuzaki K., Kitazato K. T., Mizobuchi Y., Kuwayama K., Kageji T., Nagahiro S., Akt2 and Akt3 play a pivotal role in malignant gliomas. Neuro-Oncology 2010 12 3 221 232 2-s2.0-77952309277 10.1093/neuonc/nop026
5. Liu P., Cheng H., Roberts T. M., Zhao J. J., Targeting the phosphoinositide 3-kinase pathway in cancer. Nature Reviews Drug Discovery 2009 8 8 627 644 2-s2.0-68249093818 10.1038/nrd2926
6. Jiang B.-H., Liu L.-Z., Role of mTOR in anticancer drug resistance: perspectives for improved drug treatment. Drug Resistance Updates 2008 11 3 63 76 2-s2.0-46149092748 10.1016/j.drup.2008.03.001
7. Jiang B.-H., Liu L.-Z., PI3K/PTEN signaling in tumorigenesis and angiogenesis. Biochimica et Biophysica Acta-Proteins and Proteomics 2008 1784 1 150 158 2-s2.0-38149015503 10.1016/j.bbapap.2007.09.008
8. Geering B., Cutillas P. R., Nock G., Gharbi S. I., Vanhaesebroeck B., Class IA phosphoinositide 3-kinases are obligate p85-p110 heterodimers. Proceedings of the National Academy of Sciences of the United States of America 2007 104 19 7809 7814 2-s2.0-34249931118 10.1073/pnas.0700373104
9. Fresno Vara J. Á., Casado E., de Castro J., Cejas P., Belda-Iniesta C., González-Barón M., P13K/Akt signalling pathway and cancer. Cancer Treatment Reviews 2004 30 2 193 204 2-s2.0-1642617693 10.1016/j.ctrv.2003.07.007
10. Voigt P., Dorner M. B., Schaefer M., Characterization of p87PIKAP, a novel regulatory subunit of phosphoinositide 3-kinase γ that is highly expressed in heart and interacts with PDE3B. Journal of Biological Chemistry 2006 281 15 9977 9986 2-s2.0-33744518663 10.1074/jbc.M512502200
11. Carnero A., Blanco-Aparicio C., Renner O., Link W., Leal J. F. M., The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications. Current Cancer Drug Targets 2008 8 3 187 198 2-s2.0-43749120732 10.2174/ 156800908784293659
12. Samuels Y., Velculescu V. E., Oncogenic mutations of PIK3CA in human cancers. Cell Cycle 2004 3 10 1221 1224 2-s2.0-13944284494
13. Sternberger M., Schmiedeknecht A., Kretschmer A., Gebhardt F., Leenders F., Czauderna F., von Carlowitz I., Engle M., Giese K., Beigelman L., Klippel A., GeneBlocs are powerful tools to study and delineate signal transduction processes that regulate cell growth and transformation. Antisense and Nucleic Acid Drug Development 2002 12 3 131 143 2-s2.0-0035992694
14. Samuels Y., Wang Z., Bardelli A., Silliman N., Ptak J., Szabo S., Yan H., Gazdar A., Powell S. M., Riggins G. J., Willson J. K. V., Markowitz S., Kinzler K. W., Vogelstein B., Velculescu V. E., High frequency of mutations of the PIK3CA gene in human cancers. Science 2004 304 5670, article 554 2-s2.0-11144358645 10.1126/science.1096502
15. Hafsi S., Pezzino F. M., Candido S., Ligresti G., Spandidos D. A., Soua Z., McCubrey J. A., Travali S., Libra M., Gene alterations in the PI3K/PTEN/AKT pathway as a mechanism of drug-resistance. International Journal of Oncology 2012 40 3 639 644 2-s2.0-84857184141 10.3892/ijo.2011.1312
16. Gallia G. L., Rand V., Siu I.-M., Eberhart C. G., James C. D., Marie S. K. N., Oba-Shinjo S. M., Carlotti C. G., Caballero O. L., Simpson A. J. G., Brock M. V., Massion P. P., Carson B. S. Sr., Riggins G. J., PIK3CA gene mutations in pediatric and adult glioblastoma multiforme. Molecular Cancer Research 2006 4 10 709 714 2-s2.0-33750596946 10.1158/1541-7786.MCR-06-0172
17. Gymnopoulos M., Elsliger M.-A., Vogt P. K., Rare cancer-specific mutations in PIK3CA show gain of function. Proceedings of the National Academy of Sciences of the United States of America 2007 104 13 5569 5574 2-s2.0-34248369435 10.1073/pnas.0701005104
18. Datta S. R., Dudek H., Xu T., Masters S., Haian F., Gotoh Y., Greenberg M. E., Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery. Cell 1997 91 2 231 241 2-s2.0-0030702123 10.1016/S0092- 8674(00)80405-5
19. Fan Q.-W., Knight Z. A., Goldenberg D. D., Yu W., Mostov K. E., Stokoe D., Shokat K. M., Weiss W. A., A dual PI3 kinase/mTOR inhibitor reveals emergent efficacy in glioma. Cancer Cell 2006 9 5 341 349 2-s2.0-33646382364 10.1016/j.ccr.2006.03.029
20. Kandel E. S., Hay N., The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB. Experimental Cell Research 1999 253 1 210 229 2-s2.0-0033604585 10.1006/excr.1999.4690
21. Mellinghoff I. K., Wang M. Y., Vivanco I., Haas-Kogan D. A., Zhu S., Dia E. Q., Lu K. V., Yoshimoto K., Huang J. H. Y., Chute D. J., Riggs B. L., Horvath S., Liau L. M., Cavenee W. K., Nagesh Rao P., Beroukhim R., Peck T. C., Lee J. C., Sellers W. R., Stokoe D., Prados M., Cloughesy T. F., Sawyers C. L., Mischel P. S., Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors. The New England Journal of Medicine 2005 353 19 2012 2024 2-s2.0-27744606737 10.1056/NEJMoa051918
22. Nakatani K., Thompson D. A., Barthel A., Sakaue H., Liu W., Weigel R. J., Roth R. A., Up-regulation of Akt3 in estrogen receptor-deficient breast cancers and androgen-independent prostate cancer lines. Journal of Biological Chemistry 1999 274 31 21528 21532 2-s2.0-0033618371 10.1074/jbc.274.31.21528
23. Del Peso L., González-García M., Page C., Herrera R., Nuñez G., Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 1997 278 5338 687 689 2-s2.0-1842333237 10.1126/science.278.5338.687
24. Cardone M. H., Roy N., Stennicke H. R., Salvesen G. S., Franke T. F., Stanbridge E., Frisch S., Reed J. C., Regulation of cell death protease caspase-9 by phosphorylation. Science 1998 282 5392 1318 1321 2-s2.0-0032515027
25. Brunet A., Bonni A., Zigmond M. J., Lin M. Z., Juo P., Hu L. S., Anderson M. J., Arden K. C., Blenis J., Greenberg M. E., Akt promotes cell survival by phosphorylating and inhibiting a forkhead transcription factor. Cell 1999 96 6 857 868 2-s2.0-0033582929
26. Kops G. J. P. L., De Ruiter N. D., De Vries-Smits A. M. M., Powell D. R., Bos J. L., Burgering B. M. T., Direct control of the forkhead transcription faotor AFX by protein kinase B. Nature 1999 398 6728 630 634 2-s2.0-0033560896 10.1038/19328
27. Stein G. H., T98G: an anchorage-independent human tumor cell line that exhibits stationary phase G1 arrest in vitro. Journal of Cellular Physiology 1979 99 1 43 54 2-s2.0-0018408665
28. Miller T. W., Rexer B. N., Garrett J. T., Arteaga C. L., Mutations in the phosphatidylinositol 3-kinase pathway: role in tumor progression and therapeutic implications in breast cancer. Breast Cancer Research 2011 13 6, article 224 2-s2.0-80755127903 10.1186/bcr3039
29. Knobbe C. B., Reifenberger G., Genetic alterations and aberrant expression of genes related to the phosphatidyl-inositol-3′ kinase/protein kinase B (Akt) signal transduction pathway in glioblastomas. Brain Pathology 2003 13 4 507 518 2-s2.0-0242499482
30. Brognard J., Clark A. S., Ni Y., Dennis P. A., Akt/pbotein kinace B is constitutively active in non-small cell lung cancer cells and promotes cellular survival and resistance to chemotherapy and radiation. Cancer Research 2001 61 10 3986 3997 2-s2.0-0035872199
31. Konishi H., Kuroda S., Tanaka M., Matsuzaki H., Ono Y., Kameyama K., Haga T., Kikkawa U., Molecular cloning and characterization of a new member of the RAC protein kinase family: association of the pleckstrin homology domain of three types of RAC protein kinase with protein kinase C subspecies and β γ subunits of G proteins. Biochemical and Biophysical Research Communications 1995 216 2 526 534 2-s2.0-0028799420 10.1006/bbrc.1995.2654
32. Chin Y. R., Toker A., Function of Akt/PKB signaling to cell motility, invasion and the tumor stroma in cancer. Cellular Signalling 2009 21 4 470 476 2-s2.0-59749095009 10.1016/j.cellsig.2008.11.015
33. Duronio V., The life of a cell: apoptosis regulation by the PI3K/PKB pathway. Biochemical Journal 2008 415 3 333 344 2-s2.0-58149175555 10.1042/BJ20081056
34. Matheny R. W. Jr., Adamo M. L., Current perspectives on akt akt-ivation and akt-ions. Experimental Biology and Medicine 2009 234 11 1264 1270 2-s2.0-70350560575 10.3181/0904-MR-138
35. Young C. D., Anderson S. M., Sugar and fat-that's where it's at: metabolic changes in tumors. Breast Cancer Research 2008 10 article 202
36. Ždychov J., Komers R., Emerging role of Akt kinase/protein kinase B signaling in pathophysiology of diabetes and its complications. Physiological Research 2005 54 1 1 16 2-s2.0-14944381279
37. Holland E. C., Celestino J., Dai C., Schaefer L., Sawaya R. E., Fuller G. N., Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice. Nature Genetics 2000 25 1 55 57 2-s2.0-0034020459 10.1038/75596
38. Kim J.-H., Zheng L. T., Lee W.-H., Suk K., Pro-apoptotic role of integrin β 3 in glioma cells. Journal of Neurochemistry 2011 117 3 494 503 2-s2.0-79954414405 10.1111/j.1471-4159.2011.07219.x
39. Kanzawa T., Germano I. M., Komata T., Ito H., Kondo Y., Kondo S., Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells. Cell Death and Differentiation 2004 11 4 448 457 2-s2.0-1842865745 10.1038/sj.cdd.4401359
40. Darzynkiewicz Z., Robinson J. P., Crissman H. A., Flow Cytometry. Methods in Cell Biology 1994 41-42 San Diego, Calif, USA Academic Press
41. Henery S., George T., Hall B., Basiji D., Ortyn W., Morrissey P., Quantitative image based apoptotic index measurement using multispectral imaging flow cytometry: a comparison with standard photometric methods. Apoptosis 2008 13 8 1054 1063 2-s2.0-47349112642 10.1007/s10495-008-0227-4
42. Zong W.-X., Li C., Hatzivassiliou G., Lindsten T., Yu Q.-C., Yuan J., Thompson C. B., Bax and Bak can localize to the endoplasmic reticulum to initiate apoptosis. Journal of Cell Biology 2003 162 1 59 69 2-s2.0-0037810844 10.1083/jcb.200302084
43. Masure S., Haefner B., Wesselink J.-J., Hoefnagel E., Mortier E., Verhasselt P., Tuytelaars A., Gordon R., Richardson A., Molecular cloning, expression and characterization of the human serine/threonine kinase Akt-3. European Journal of Biochemistry 1999 265 1 353 360 2-s2.0-0033214101 10.1046/j.1432-1327.1999.00774.x
44. Oltvai Z. N., Milliman C. L., Korsmeyer S. J., Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programed cell death. Cell 1993 74 4 609 619 2-s2.0-0027166048 10.1016/0092-8674(93)90509-O
45. Yang E., Zha J., Jockel J., Boise L. H., Thompson C. B., Korsmeyer S. J., Bad, a heterodimeric partner for Bcl-xL and Bcl-2, displaces bax and promotes cell death. Cell 1995 80 2 285 291 2-s2.0-0028809209
46. Opel D., Westhoff M.-A., Bender A., Braun V., Debatin K.-M., Fulda S., Phosphatidylinositol 3-kinase inhibition broadly sensitizes glioblastoma cells to death receptor- and drug-induced apoptosis. Cancer Research 2008 68 15 6271 6280 2-s2.0-51049112961 10.1158/0008-5472.CAN-07-6769
47. Koseoglu S., Lu Z., Kumar C., Kirschmeier P., Zou J., AKT1, AKT2 and AKT3-dependent cell survival is cell line-specific and knockdown of all three isoforms selectively induces apoptosis in 20 human tumor cell lines. Cancer Biology and Therapy 2007 6 5 755 762 2-s2.0-34548266099
48. Stahl J. M., Sharma A., Cheung M., Zimmerman M., Cheng J. Q., Bosenberg M. W., Kester M., Sandirasegarane L., Robertson G. P., Deregulated Akt3 activity promotes development of malignant melanoma. Cancer Research 2004 64 19 7002 7010 2-s2.0-4944249733 10.1158/0008-5472.CAN-04-1399
49. Sunayama J., Matsuda K.-I., Sato A., Tachibana K., Suzuki K., Narita Y., Shibui S., Sakurada K., Kayama T., Tomiyama A., Kitanaka C., Crosstalk between the PI3K/mTOR and MEK/ERK pathways involved in the maintenance of self-renewal and tumorigenicity of glioblastoma stem-like cells. Stem Cells 2010 28 11 1930 1939 2-s2.0-78649831949 10.1002/stem.521